Company intelligence / Profile preview
Cell Reprogramming & Therapeutics LLC
Wauwatosa, Wisconsin, USApmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Cell Reprogramming & Therapeutics LLC is developing proprietary cell reprogramming technologies aimed at producing patient-specific cells for the treatment of major neurological disorders. The company is focused on preclinical development, with a strong emphasis on regenerative medicine approaches targeting diseases of the central nervous system. No clinical trial results are currently available in the public domain[1][2].
- Therapeutic areas
- OncologyNeurology
- Modalities
- Cell-based therapiesCellular models for drug discovery and disease modeling[1][4]
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Cell Reprogramming & Therapeutics LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell Reprogramming & Therapeutics LLC.